🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy to be participating in the ASTCT 2024 Leadership course. I’m learning so much from giants in the field of allogeneic transplant. @BldCancerDoc Krishna Komanduri, MD, FASTCT Dr. Elizabeth Shpall Corey Cutler

I learnt so much over the last 2 days about running a BMT program. I highly recommend ASTCT Leadership course to mid level BMT faculty considering a leadership role in the future. Excellent opportunity to network with leaders in the field.

It’s starting to feel real now. I just listed my Lexington house for sale so it’s time to make a Twitter announcement . I have accepted a BMT position Moffitt Cancer Center and will be moving to Tampa Florida in July. It’s been my pleasure working Markey Cancer Center for the last 8 years.

Last clinic day Markey Cancer Center. Over the last 8 years I have made some great friends, friendships I will cherish for a lifetime. I will definitely miss my #MarkeyFamily. However, I am excited about starting my next chapter of my life Moffitt Cancer Center

“Always leave a place better than you found it.” Thank you for the lovely gift and sentiment from the Hem-BMT Division Markey Cancer Center.

Last day of work Markey Cancer Center. The past 8 years have been a great journey. My clinical skills as a leukemia, BMT doctor has expanded tremendously and I have made some wonderful friends along the way. UK HemOnc Fellows University of Kentucky College of Medicine Moffitt Cancer Center

Also ranked high performing in Leukemia, Lymphoma and Myeloma. Congratulations Markey Hematology/BMT/CT team. Markey Cancer Center University of Kentucky College of Medicine UK HealthCare

🩸 ASH is launching CHAMP to support career growth and development in #hematology! Join our town hall on Nov 8 at 12 noon ET to learn more about this exciting new program. RSVP today! Register now: ow.ly/alNg50TM6Wu #Mentorship #Fellows #ASHTrainee

ELN 2022 - did not adequately stratify AML patients TX - aza/ven based on OS 4 gene model (TP53, FLT3, NRAS, KRAS) was better @ stratifing this group (TP53- adverse, any other mutation - intermediate, none- favorable) doi.org/10.1182/blood.…

Pickle Ball Court #ASH24. ASH always stepping up their game each year.

LIVE from #Tandem25: Nelli Bejanyan, MD (Nelli Bejanyan MD) presents a Phase I trial of ex vivo expanded donor gamma delta T cell (GDT) immunotherapy to prevent AML relapse after allo-HCT. Key findings: • GDT infusion was safe with no dose-limiting toxicities or GVHD. • 80%+

LIVE at #Tandem25: Joseph Pidala, MD, PhD presents his CIBMTR analysis on ‘Determinants of Immune Suppression Discontinuation in the Modern Era’ based on 18,642 subjects. Key findings: • 37.1% of subjects achieved immune suppression discontinuation (ISD), with a median of 6.8

At #Tandem25, Rawan Faramand, MD, joined Nelli Bejanyan, MD (Nelli Bejanyan MD) to discuss whether allogeneic transplants can be safely performed in patients who have previously received B-cell therapy, as well as the research that excites her most in her field. #MoffittTandem25

Embracing the future of Artificial Intelligence.

A Moffitt patient made history as the first to receive a second CAR T therapy for ovarian cancer, a breakthrough made possible by cancer research. After her initial treatment in June 2023, her care team is hopeful that this second infusion will cure her ovarian cancer once and

Congratulations to this year's recipient of the Moffitt Researcher of the Year award, Frederick Locke, MD (Frederick L. Locke)! He is recognized for his groundbreaking work in CAR T-cell therapy, leadership in key clinical trials and commitment to mentoring future scientists.

Moffitt Cancer Center is proud to be the first standalone cancer center in the world to open a Nikon Center of Excellence! This prestigious achievement reflects our commitment to cutting-edge imaging technology and groundbreaking cancer research.

An inspirational piece I wrote for the Trinidad Newspaper - outlining my academic journey. True success lies after SEA trinidadexpress.com/opinion/letter… via Trinidad and Tobago Express Newspapers